Abstract:The development of a highly efficient, low-toxicity, ultrasmall ferrite nanoparticle-based T-1 contrast agent for high-resolution magnetic resonance imaging (MRI) is highly desirable. However, the correlations between the chemical compositions, in vitro T-1 relaxivities, in vivo nano-bio interactions and toxicities remain unclear, which has been a challenge in optimizing the in vivo T-1 contrast efficacy. Methods: Ultrasmall (3 nm) manganese ferrite nanoparticles (MnxFe3-xO4) with different doping concentrations of the manganese ions (x = 0.32, 0.37, 0.75, 1, 1.23 and 1.57) were used as a model system to investigate the composition-dependence of the in vivo T-1 contrast efficacy. The efficacy of liver-specific contrast-enhanced MRI was assessed through systematic multiple factor analysis, which included the in vitro T1 relaxivity, in vivo MRI contrast enhancement, pharmacokinetic profiles (blood half-life time, biodistribution) and biosafety evaluations (in vitro cytotoxicity testing, in vivo blood routine examination, in vivo blood biochemistry testing and H&E staining to examine the liver). Results: With increasing Mn doping, the T-1 relaxivities initially increased to their highest value of 10.35 mM(-1)s(-1), which was obtained for Mn0.75Fe2.25O4, and then the values decreased to 7.64 m M(-1)s(-1), which was obtained for the Mn1.57Fe1.43O4 nanoparticles. Nearly linear increases in the in vivo MRI signals (Delta SNR) and biodistributions (accumulation in the liver) of the MnxFe3-xO4 nanoparticles were observed for increasing levels of Mn doping. However, both the in vitro and in vivo biosafety evaluations suggested that MnxFe3-xO4 nanoparticles with high Mn-doping levels (x > 1) can induce significant toxicity. Conclusion: The systematic multiple factor assessment indicated that the MnxFe3-xO4 (x = 0.75-1) nanoparticles were the optimal T-1 contrast agents with higher in vivo efficacies for liver-specific MRI than those of the other compositions of the MnxFe3-xO4 nanoparticles. Our work provides insight into the optimization of ultrasmall ferrite nanoparticle-based T-1 contrast agents by tuning their compositions and promotes the translation of these ultrasmall ferrite nanoparticles for clinical use of high-performance contrast-enhanced MRI.

Structure-Relaxivity Mechanism of an Ultrasmall Ferrite Nanoparticle T1 MR Contrast Agent: the Impact of Dopants Controlled Crystalline Core and Surface Disordered Shell.

Structure–Relaxivity Mechanism of an Ultrasmall Ferrite Nanoparticle T 1 MR Contrast Agent: The Impact of Dopants Controlled Crystalline Core and Surface Disordered Shell

Ultrasmall Ferrite Nanoparticles Synthesized Via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T1 Magnetic Resonance Imaging Contrast Agent.

Composition-Tunable Ultrasmall Manganese Ferrite Nanoparticles: Insights into their In Vivo T 1 Contrast Efficacy.

High-performance Nanostructured MR Contrast Probes.

Fe2+-Dominated Relaxometric Properties of Iron Oxide Nanoparticles as MRI Contrast Agents

Time-Dependent T-1-T-2 Switchable Magnetic Resonance Imaging Realized by C(rgdyk) Modified Ultrasmall Fe3O4 Nanoprobes

Precisely Tuning the Contrast Properties of ZnxFe3–xO4 Nanoparticles in Magnetic Resonance Imaging by Controlling Their Doping Content and Size

Gd3+‐Ion‐Doped Upconversion Nanoprobes: Relaxivity Mechanism Probing and Sensitivity Optimization

Engineering Manganese Ferrite Shell on Iron Oxide Nanoparticles for Enhanced T1 Magnetic Resonance Imaging.

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Core@Shell Fe3o4@Mn2+-Doped Nayf4:Yb/Tm Nanoparticles For Triple-Modality T-1/T-2-Weighted Mri And Nir-To-Nir Upconversion Luminescence Imaging Agents

Inorganic Nanoparticle-Based T1 and T1/T2 Magnetic Resonance Contrast Probes.

Structure–Relaxivity Relationships of Magnetic Nanoparticles for Magnetic Resonance Imaging

Composition Tunable Manganese Ferrite Nanoparticles for Optimized T-2 Contrast Ability

Manganese Oxide/metal-Organic Frameworks-Based Nanocomposites for Tumr Micro-environment Sensitive 1H/19F Dual-mode Magnetic Resonance Imaging in Vivo

Core-shell Fe 3O 4@NaLuF 4: Yb,Er/Tm nanostructure for MRI, CT and upconversion luminescence tri-modality imaging

Reticular Chemistry of the Fcu‐Type Gd(III)‐Doped Metal–Organic Framework for T1‐Weighted Magnetic Resonance Imaging

Renal-clearable zwitterionic conjugated hollow ultrasmall Fe 3 O 4 nanoparticles for T 1 -weighted MR imaging in vivo.

Dysprosium-Modified Gold Nanoparticles As T2ex Contrast Agents for Magnetic Resonance Imaging

Dysprosium-Modified Gold Nanoparticles as T 2ex Contrast Agents for Magnetic Resonance Imaging